Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease
1 other identifier
observational
60
1 country
1
Brief Summary
the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases. And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2024
CompletedFirst Posted
Study publicly available on registry
November 27, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedNovember 27, 2024
November 1, 2024
6 months
November 22, 2024
November 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
intensive care unit admission of the patients due to progression of the disease complications.
Primary outcome will be ICU admission due to progression of the disease complications.
through study completion, an average of 6 months
Secondary Outcomes (1)
mortality within duration of hospital admission
through study completion, an average of 6 months
Interventions
blood samples for CBC parameters , peripheral blood smear, bilirubin levels and kidney function tests
Eligibility Criteria
patients admitted in Internal Medicine department and Intermediate care unit at sohag university hospital
You may qualify if:
- Adults aged 18 years and older.
- Patients diagnosed with acquired hemolytic anemia.
- Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
- Patients (or their legal representatives) must provide informed
You may not qualify if:
- Patients with underlying neoplastic diseases.
- Patients with hereditary hemolytic anemia.
- Patients or their representatives who do not consent to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Faculty of Medicine Sohag University
Sohag, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
November 22, 2024
First Posted
November 27, 2024
Study Start
December 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
November 27, 2024
Record last verified: 2024-11